https://www.sirius-medical.com/news/2020/07/13/sirius-medical-raises-e4-4m-in-series-a-funding-to-launch-sirius-pintuition-a-non-radioactive-localization-system-to-improve-breast-cancer-surgery/
Stay informed about the latest updates from Curie Capital and the ongoing activities within our portfolio companies.
Avidicure CEO Arthur Lahr spoke with Nuala Moran of BioWorld News about their $50M seed funding and how AVC-Boosters are...
AVC-Boosters are designed as dual agonistic antibodies to safely deliver targeted and potentmonotherapy with broad application...
Cincinnati, Ohio, US and Eindhoven, Netherlands – February 27, 2025 - Sirius Medical, the innovator of Surgical Marker...
Eindhoven, the Netherlands – 4 February 2025 – As World Cancer Day is observed, Dutch medical device company Sirius...
TGD001 is being developed to offer patients with clotting disorders a faster, safer and more effective treatment than today’s...
Financing co-led by Johnson & Johnson Innovation – JJDC, Inc., Forbion and Novartis Venture Fund Lead first-in-class product...